Login / Signup

Design and development of the MacTSQ measure of satisfaction with treatment for macular conditions used within the IVAN trial.

Jan MitchellClare Bradley
Published in: Journal of patient-reported outcomes (2018)
The MacTSQ will be valuable in investigating treatment satisfaction in clinical trials of new treatments or in a routine clinic situation and may highlight ways to improve patients' experience of treatment.
Keyphrases
  • clinical trial
  • primary care
  • randomized controlled trial
  • end stage renal disease
  • optical coherence tomography
  • phase iii
  • phase ii